Vor Biopharma Inc.
USD20.05
+2.60 (+14.90%)
CEO
Jean-Paul Kress
IPO Date
2021-02-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.40
Prev. Close
$17.45
Day Low
$17.28
Day High
$20.25
52W Low
$6.50
52W High
$53.00
Market Cap
$0.14B
Volume
1.34M
| 42,658 |
| $20.10 |
| 12 Jun 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | A-Award | Acquired | 57,162 | $14.09 |
| 12 Jun 2026 | Detheux Michel | director | A-Award | Acquired | 57,162 | $14.09 |
| 12 Jun 2026 | Namouni Fouad | director | A-Award | Acquired | 56,549 | $14.09 |
| 12 Jun 2026 | Joustra Wouter | director | A-Award | Acquired | 57,162 | $14.09 |
| 12 Jun 2026 | Kalir Erez | director | A-Award | Acquired | 57,162 | $14.09 |
| 12 Jun 2026 | Cumbo Alexander | director | A-Award | Acquired | 56,345 | $14.09 |
| 12 Jun 2026 | Beckman Daniella | director | A-Award | Acquired | 53,283 | $14.09 |
| 12 Jun 2026 | Levin Andrew David | director | A-Award | Acquired | 57,162 | $14.09 |